Terbogrel特波格雷,149979-74-8

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Terbogrel

CAS No. : 149979-74-8

MCE 国际站：Terbogrel

产品活性：Terbogrel 是一种可口服的 thromboxane A2 受体拮抗剂，和 thromboxane A2 synthase 的抑制剂，IC₅₀ 值均约为 10 nM。

研究领域：GPCR/G Protein

作用靶点：Prostaglandin Receptor

In Vitro: Pretreatment of platelets with terbogrel 1 μM completely inhibits thrombin-induced thromboxane A2 formation (2±1 ng/mL) but does not result in any inhibition of platelet aggregation. Terbogrel (1 μM) completely inhibits U46619-induced platelet aggregation, and the IC₅₀ value is 10 nM. Terbogrel inhibits both platelet aggregation and thromboxane A2 formation with an IC₅₀ of about 10 nM. Terbogrel inhibits the thromboxane A2 synthase in human gel-filtered platelets with an IC₅₀ value of 4.0 ± 0.5 nM. Terbogrel blocks the thromboxane A2/endoperoxide receptor on washed human platelets with an IC₅₀ of 11 ± 6 nM (n = 2) and with an IC₅₀ of 38 ± 1 nM (n = 15) in platelet-rich plasma. Terbogrel inhibits the collagen-induced platelet aggregation in human platelet-rich plasma and whole blood with an IC₅₀ of 310 ± 18 nM (n = 8) and 52 ± 20 nM (n = 6), respectively.

In Vivo: Terbogrel (0.1−3.0 mg/kg) demonstrates an impressive antithrombotic efficacy in rabbits. Terbogrel (10 mg/kg, po) is rapidly and well (90%) absorbed with a systemic availability of about 30% in rats.

相关产品：Prostaglandin E2  |  EIPA  |  Prostaglandin E1  |  Tranilast  |  PF-04418948  |  U-46619  |  Iloprost  |  Prostaglandin D2  |  ONO-AE3-208  |  Dinoprost  |  Palupiprant  |  Latanoprost  |  Selexipag  |  16,16-Dimethyl prostaglandin E2  |  Treprostinil  |  DG-041  |  Grapiprant  |  L-798106  |  GW627368  |  Fevipiprant  |  Asapiprant  |  AH 6809  |  L-161982  |  Laropiprant  |  Bimatoprost  |  CJ-42794  |  MF498  |  Beraprost sodium  |  Ramatroban

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds